Who Paid My Doc
Fruquintinib
Research payments
$1,039,259
Through program year 2025, $1,039,259 in research payments was reported against Fruquintinib, across 87 payments, paid by Takeda Pharmaceuticals U.S.A., Inc..
- Paid by
- Takeda Pharmaceuticals U.S.A., Inc.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
2 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $938,087 | 83 |
| 2024 | Research | $101,172 | 4 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Srilata Gundala Hinsdale, IL Named on 15 payments
- Brian Smith Bridgeton, MO Named on 7 payments
- Julio Peguero Corpus Christi, TX Named on 6 payments
- Nikolaos Andreatos Saint Louis, MO Named on 5 payments
- Sandra Algaze Los Angeles, CA Named on 5 payments
- Jamal Misleh Newark, DE Named on 4 payments
- Marcus Noel Rochester, NY Named on 4 payments
- Neel Dharia Mesa, AZ Named on 4 payments
- Anita Turk Indianapolis, IN Named on 4 payments
- Panayotis Ledakis Baltimore, MD Named on 4 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.